Study of Cgrp-Receptors in Human Isolated Middle Meningeal Arteries Using Bibn4096Bs, Compound 1, and HαCgrp(8-37)
Author(s) -
Z. Razzaque,
David E. Shaw,
Mark G. Bock,
L. Maskell,
J. D. Pickard,
D. Sirinathsinghji,
J. Longmore
Publication year - 2001
Publication title -
the scientific world journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.453
H-Index - 93
eISSN - 2356-6140
pISSN - 1537-744X
DOI - 10.1100/tsw.2001.437
Subject(s) - calcitonin gene related peptide , adrenomedullin , amylin , receptor , middle meningeal artery , calcitonin , endocrinology , calcitonin receptor , medicine , chemistry , pharmacology , neuroscience , biology , neuropeptide , surgery , embolization , islet , insulin
Calcitonin, CGRP, adrenomedullin, and amylin require both CRLR (calcitonin-gene receptor like receptor) and receptor activity modifying proteins (RAMP1, RAMP2, and RAMP3) in different combinations for expression of selective, functional receptors[1]. We investigated whether the antagonists BIBN4096BS[2], Compound 1 (WO98/11128, [3]), and CGRP(8-37) are functionally selective for CGRP receptors in human middle meningeal arteries (HMMA).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom